Skip to main content

Table 1 In- and exclusion criteria

From: Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson’s disease

Inclusion criteria

Exclusion criteria

Idiopathic Parkinson’s disease diagnosed by a neurologist

Medication:

• Beta-blockers and/or anti-psychotics

Hoehn & Yahr stage ≤2 (tested in off state)

Comorbidity:

• Neurologic or orthopedic co-morbidities that make it impossible to cycle or perform stretching exercises (safely)

• Contra-indications for aerobic exercise including diagnosed cardiac diseases, diagnosed but poorly controlled diabetes

• mellitus or pulmonary diseases.

• Psychiatric diseases: major depressive disorder, severe or moderate depressive episode or any form of psychosis), diagnosed by a psychiatrist in the last year.

• Dementia: MMSE <24

Age 30–75 years

Inability to fill out questionnaires or perform a computer task (i.e. due to poor vision, inability to read Dutch (illiteracy or foreign language))

Sedentary lifestyle [16]

Facilities:

• No internet at home

Parkinson medication:

Availability/compliance:

• Stable dopaminergic medication dose (both levodopa and/or a dopamine agonist are allowed) for at least one month before the study

• Unavailable for more than 10% (approximately 2.5 weeks) of the 6 months

• No treatment and deemed unlikely to start treatment within the next month by their treating neurologist